CASE STUDY: EVOLUTION IN THE MEDICAL DEVICE SUPPLY CHAIN Cardinal Health and DHL discuss trust and partnership in logistics and back office
With
Steve Thompsett, CEO
DHL Supply Chain Australia and New Zealand
Michael Gardner,
(Former) VP Life Sciences & Healthcare
DHL Supply Chain Australia
Shane McCormack,
Senior Manager Supply Chain
Cardinal Health
Australian Health Journal segment
Filmed in Sydney | April 2025
Supply chain and logistics involve managing products globally, from manufacturing to distribution. This includes international shipping via air and sea, storing products in temperature-controlled warehouses, and delivering them to pharmacies, medical wholesalers, and hospitals within the domestic market.
Michael Gardner, (Former) VP Life Sciences & Healthcare, DHL Supply Chain Australia spoke to Australian Health Journal about the medical device industry being particularly complex; onboarding a new customer at DHL supply chain demands thorough preparation. This process involves understanding the customer’s operations and the lifecycle of their products, from their arrival at the warehouse to their use in patient care. Insight into the customer’s expectations is crucial to ensure seamless operations.
For Cardinal Health, a global manufacturer and distributor of medical products, the process begins when products arrive in Australia and are cleared by customs before being stored at their Sydney warehouse. From here, they fulfil orders for various clients, including hospitals and wholesalers, supported by DHL’s logistics services.
In this case study, Australian Health Journal was given the opportunity to talk to both the logistics provider and the end medical technology client in what is an evolving medical device supply chain.
Challenges in Australia include a limited manufacturing workforce and the distances to raw material sources, with all imported products being finished goods. Compliance with safety and regulatory standards is essential. In addition to logistics, DHL provides value-added services like equipment repairs and a 4PL service, which includes customer service support and accounts receivable, enhancing efficiency for Cardinal Health.
Credit: MedTech24 Conference, hosted by Medical Technology Association of Australia (MTAA) in Sydney, October 2024.
Source: Written by AUDIENCED, with use of generative AI on transcript
-
ICTD: Clinical trials in regional, rural and remote Australia
To mark International Clinical Trials Day 2026, Australian Health Journal commences a 4 part special series leaving up to 20th May. Through conversations with leading researchers, clinicians and trial organisations, the series highlights achievements in the year that was for clinical trials. The first segment is an example of how in-person clinical trial access has improved for regional, rural and remote communities.
-
World-first clinical trial improves patient outcomes for kidney transplants
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Australian Health Journal spoke with the lead-author of the study, RAH Nephrologist and University of Adelaide researcher, Dr Michael Collins.
-
Study: First time stroke survivors have substantial immediate and accelerated long term cognitive decline
New evidence from the Centre for Healthy Brain Ageing (CHeBA) indicates that older adults who experience a stroke for the first time will have substantial immediate and accelerated long term-cognitive decline.
